4th Quarter - Termination

THE NICKLES GROUP, LLC for SHIRE PHARMACEUTICALS LLC

Firm
Client
Income
$52,500
Expenses
—
Terminated
Dec 31, 2018

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Monitored H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act and Continuing Appropriations Act. Monitored H.R. 695, Further Additional Continuing Appropriations Act of 2019.

LobbyistCovered position, as disclosed
RACHEL JONES HENSLER —
EMILY PORTER —
KATHERINE RAAB —
MARY BETH SAVARY TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States

Bills named: H.R. 695 (115th), H.R. 6157 (115th)

Taxation/Internal Revenue Code TAX

Monitor implementation of The Tax Cut and Jobs Act, as it relates to corporate tax reform, the taxation of multinationals, and the orphan drug tax credit.

LobbyistCovered position, as disclosed
RACHEL JONES HENSLER —

Contacted: SENATE; Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES

Health Issues HCR

Orphan Drug Act and issues regarding access to care for those with rare diseases. H.R. 5803, SAFETY Act of 2018, S. 2680, Opioid Crisis Response Act of 2018, S. 2891, Fighting the Opioid Epidemic with Sunshine Act of 2018, S. 3000, Patient Advocacy Transparency Act, and H.R. 6, SUPPORT for Patients and Communities Act as they related to issues regarding controlled substances. Monitored issues related to newborn screening.

LobbyistCovered position, as disclosed
EMILY PORTER —
KATHERINE RAAB —
MARY BETH SAVARY TAYLOR —

Contacted: SENATE; Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES

Bills named: S. 2891 (115th), S. 3000 (115th), H.R. 6 (115th), H.R. 5803 (115th), S. 2680 (115th)

Medicare/Medicaid MMM

Issues related to pharmaceutical prices. H.R. 6, SUPPORT for Patients and Communities Act; S.2680, Opioid Crisis Response Act of of 2018 and issues related to controlled substances; monitored S. 2554 / H.R. 6143, the Patient Right to Know Drug Prices Act; monitored H.R. 3325, the Advancing Care for Exceptional Kids Act (ACE Kids) and H.R. 7212, IMPROVE Act. S. 1194, Medical Nutrition Equity Act. H.R. 4724, Medicare IVIG Access Enhancement Act.

LobbyistCovered position, as disclosed
EMILY PORTER —
KATHERINE RAAB —
MARY BETH SAVARY TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States

Bills named: S. 2554 (115th), H.R. 6 (115th), H.R. 4724 (115th), H.R. 3325 (115th), H.R. 6143 (115th), S. 2680 (115th), H.R. 7212 (115th), S. 1194 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.